ANDA 65120, held by Fresenius Kabi USA. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 65120 (Tobramycin Sulfate (Pharmacy Bulk)), held by Fresenius Kabi USA, was first approved by FDA on Nov 29, 2002, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 29, 2002 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin Sulfate (Pharmacy Bulk)EQ 40MG BASE/ML · injectable;injection | Tobramycin Sulfate | Rx |
| Feb 10, 2023 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jan 17, 2023 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jan 17, 2023 | Supplement 7Labeling · Standard review | Approved | None posted |
| Sep 26, 2005 | Supplement 2Labeling | Approved | None posted |
| Oct 21, 2004 | Supplement 1Labeling | Approved | None posted |
| Nov 29, 2002 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters